Navigation Links
China-Biotics, Inc. Reports Record Quarterly and Annual Revenue Growth for Fiscal Year 2010
Date:6/13/2010

$ -- $ -- Cash advance from a director 3,113,900 -- Proceeds from issuance of common stock 74,906,572 -- Repayment in advance from a director (7,908,948) -- NET CASH PROVIDED BY/(USED IN) FINANCING ACTIVITIES $ 70,111,524 $ -- Effect of exchange rate changes on cash $ 242,937 $ 926,439 NET INCREASE IN CASH AND CASH EQUIVALENTS BALANCES $ 84,755,331 $ 6,513,593 CASH AND CASH EQUIVALENTS BALANCES AT BEGINNING OF PERIOD 70,824,041 64,310,448 CASH AND CASH EQUIVALENTS BALANCES AT END OF PERIOD $ 155,579,372 $ 70,824,041 Supplemental of disclosure cash flow information: Interest paid $ 1,005,885 $ 808,219 Income tax paid $ 5,329,205 $ 3,119,911 Three Months Ended March 31, 2010 2009 Adjusted Net income Net Income Diluted Net Income Diluted EPS EPS Adjusted Amount 8,773,196 0.36 5,570,132 0.33 Adjustments Non-cash (losses) gains from change in fair value of convertible bonds (5,889,000) (0.23) 1,019,000 0.06 Amount per consolidated statement of operations 2,884,196 0.13 6,589,132 0.39 Fiscal Year Ended March 31, FY2010 FY2009 Adjusted Net income Net Income Diluted Net Income Diluted EPS
'/>"/>
SOURCE China-Biotics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor
2. China-Biotics, Inc. Inaugurated the Commercial Production of its New Production Facility
3. China-Biotics, Inc. Reports Third Quarter Fiscal 2010 Financial Results
4. China-Biotics, Inc. Announces Conference Call to Discuss Second Quarter Fiscal 2010 Financial Results
5. China-Biotics, Inc. Appoints New Vice President
6. China-Biotics, Inc. to Attend the SIG 3rd Annual Beijing Management Summit
7. China-Biotics, Inc. Reports First Quarter Fiscal 2010 Financial Results
8. China-Biotics, Inc. Receives High-Technology Enterprise Certification to Qualify for Preferential Income Tax Rate
9. China-Biotics, Inc. Applies for Four Patents on Probiotic Formulations
10. China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results
11. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015 CSL Behring ... Administration has accepted for review the company,s Biologics License ... single-chain (rVIII-SingleChain) for the treatment of hemophilia A. In ... Hemophilia A is a ... VIII; nearly all affected patients are male. People with ...
(Date:7/28/2015)... , July 28, 2015  Faced with ... that are palliative rather than symptomatic, the global ... few existing therapies capable of curing or significantly ... are starting to look towards regenerative medicine as ... a new paradigm in human health with the ...
(Date:7/27/2015)... ... 27, 2015 , ... This is a professional and in-depth ... overview of the industry including definitions, classifications, applications and industry chain structure. The ... landscape analysis, and key regions development status. Development policies and plans are discussed ...
(Date:7/27/2015)... , July 27, 2015 Research presented at ... will expand on the studies that led to a ... diagnostic for this disease to receive approval from the ... to breaking Ebola,s grip on West Africa ... and enabling healthcare workers to isolate and treat these ...
Breaking Biology Technology:U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 52015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 3
... combats an,alarming rise in chronic diseases, the Pharmaceutical ... new report on the next,generation of medicines in ... The report found that America,s pharmaceutical research ... - are,testing a record 633 new biotech medicines., ...
... and CHICAGO, Sept. 24 Omeros Corporation, a,Seattle-based ... million debt facility with BlueCrest Capital Finance. The ... by Omeros at closing and the,right, subject to ... $15,million. Other terms were not disclosed., "This ...
... specialty biopharmaceutical company,announces that at its Annual General Meeting today, all resolutions,contained in the notice of meeting ... ... Against Withheld** 1. To ... Emmens as a Director ...
Cached Biology Technology:New Report on 633 Biotechnology Medicines Under Development Released in Michigan 2New Report on 633 Biotechnology Medicines Under Development Released in Michigan 3Omeros and BlueCrest Announce $20 Million Debt Facility 2Results of the Annual General Meeting Held on September 24, 2008 2Results of the Annual General Meeting Held on September 24, 2008 3
(Date:6/30/2015)... HATFIELD, Pa. , June 30, 2015 ... joined the company as CEO to help further develop ... a wealth of partnering experience, having spent much of ... companies including Therakine, Amgen, Baxter Bioscience, and Johnson & ... a focus on Technology and Biotech Corporate Finance. He ...
(Date:6/26/2015)... Utah , June 26, 2015 ATL Technology, ... and devices with specialties in single use solutions, headquartered in ... of MedConx, Inc. (a California corporation ... and San Jose, Costa Rica ). ... Costa Rica with ATL Technology,s existing facility ...
(Date:6/25/2015)... SALT LAKE CITY , June 25, 2015 /PRNewswire/ ... the first steps toward a healthier, happier life. That,s ... app is designed to do. The cutting-edge, portable health ... and offers real-life solutions to help improve your lifestyle ... Sellers Association awards dinner and gala Wednesday night, USANA,s ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
... powerful class of antioxidants could one day be a potent ... antioxidants called synthetic triterpenoids blocked development of Parkinson,s in an ... days, said Dr. Bobby Thomas, neuroscientist at the Medical College ... of the study in the journal Antioxidants & Redox ...
... Award for Innovative Excellence, the Society,s highest award. ... Fulwyler, the inventor of the electrostatic cell sorter, and ... Dr. Terstappen received his Ph.D. in Applied Physics from ... pioneering cytometry research at Becton Dickinson. In 1994, ...
... July 23, 2012 Scientists at Joslin Diabetes ... (GLP-1), a gut hormone, protects against kidney disease, and ... findings, which are reported today online by Diabetes, may ... harness the actions of GLP-1 to prevent the harmful ...
Cached Biology News:Powerful class of antioxidants may be potent Parkinson's treatment 2The International Society for Advancement of Cytometry presented its 2012 awards at CYTO 2012 2The International Society for Advancement of Cytometry presented its 2012 awards at CYTO 2012 3Joslin researchers gain new understanding of diabetes and kidney disease 2Joslin researchers gain new understanding of diabetes and kidney disease 3
...
BD BioCoat Collagen IV 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of mouse collagen type IV....
... primers are designed for sequencing inserts cloned ... T7, or T3 RNA polymerase promoters, or ... supplied at a concentration of 0.1 µg/µl ... in DNA sequencing reactions using SequiTherm™ EXCEL™ ...
BD BioCoat Matrigel Matrix 35 mm Culture Dishes Coating : BD MatrigelTM Basement Membrane Matrix ,Surface : ECM/attachment factors ,Surface area : 9.6 cm2 ,Dim nominal : 35 mm x 10 mm ,Vo...
Biology Products: